Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Chairman operating in the Medical space. If you think a Chairman is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Gabriel Mecklenburg
Co-founder, Executive Chairman of Hinge Health
Follow Gabriel Mecklenburg:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Graham Richards
Chairman of Proteorex Therapeutics Inc.
Follow Graham Richards:
About : Expanding horizons to find cures
Charles Spicer
Chairman of Creo Medical
Charles is an experienced director of and adviser to public and private companies primarily in the med-tech sector. He is non-executive chairman of PuriCore plc, IXICO plc and 11 Health. He is a chair of the UK Department of Health’s Invention for Innovation (i4i) Funding Panel. Until recently he was a director of Aircraft Medical (acquired by Medtronic Inc. in December 2015) and Stanmore Implants (acquired by Stryker Inc., April 2016). He was previously chief executive of MDY Healthcare plc, a strategic healthcare investor and, prior to that, head of healthcare corporate finance at both Numis Securities and Nomura International.
Follow Charles Spicer:
About City & Guilds Group, Creo Medical, Ixico, KwickScreen, MJ Hudson: Creo Medical is a developer of electrosurgical devices.
Chas Taylor
Chief Executive Officer & Chairman of Respiratory Motion
Mr. Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a Co-founder and Director of Novate Medical, and a Director of BrightWater Medical. All three of these companies were acquired in the last three years. Previously, Mr. Taylor was the Co-founder of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with Bard Cardiovascular and General Surgical products where he had roles of increasing responsibility in general management and international sales and marketing.
Follow Chas Taylor:
About : Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
David Tuch
Founder & Executive Chairman of Lightpoint Medical
David Tuch is the Founder and CEO of Lightpoint Medical. He has more than a decade of experience in the medical imaging and pharmaceutical sectors. Previously, he was Head of Research Alliances at GE Healthcare and Head of Clinical Imaging at Novartis. Before joining industry, Dr. Tuch served on the faculty of Harvard Medical School and Massachusetts General Hospital, Department of Radiology. He is currently an Honorary Senior Lecturer in the Imperial College, Department of Bioengineering. Dr. Tuch holds a PhD from MIT and Harvard Medical School, a BA from the University of Chicago, and has completed executive education at INSEAD.
Follow David Tuch:
About Lightpoint Medical, Lucida Medical: Lightpoint Medical, a medical device company, develops intra-operative imaging technology that can detect cancer during surgery.
Chris Hand
Chairman of Abingdon Health
Follow Chris Hand:
About Molecular Vision: Abingdon Health is an innovative technology-led company focused on providing rapid and near-patient medical diagnostic testing solutions.
Quentin Pankhurst
Chairman of MediSieve
Quentin is a world expert in magnetic nanoparticles, and an academic innovator with direct experience in the medical technology sector. In 2007, he founded Endomagnetics to commercialise a device for sentinel node detection in breast cancer, serving the company as CEO until 2010 and as a board member until 2014. He played a key role in CE marking the device, which has treated more than 3,500 patients in 15 countries. A physicist by training, Quentin is the Director of the Healthcare Biomagnetics Laboratory at UCL, where he runs programmes in bio- and nanomagnetism aimed at making practicle advances in the use of magnetic nanoparticles in healthcare. He is a champion of translational R&D, for which he established the UCL Institute of Biomedical Engineering. The objective of the IBME is to bring together UCL’s excellence in academic and clinical R&D – around a thousand staff, fellows, nurses and students in 35 different centres, departments and institutes – to create the world’s best research centre for biomedical engineering.
Follow Quentin Pankhurst:
About Endomag, University College London (UCL): MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Dr Bruce Roser
Chairman & CSO of Stablepharma Ltd
Dr Bruce Roser MB BS, PhD – Chairman & Founder. Discovered the preservation properties of the resurrection plant. A distinguished international career in biomedical research with 108 refereed papers and 49 patents.
Follow Dr Bruce Roser:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Brian Howlett
Chairman of Oxford Endovascular
Brian Howlett co-founded Vascular Flow Technologies Ltd.
Follow Brian Howlett:
About Accentus Medical, ANGLE, Oxford Endovascular: Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Ken Powell
Executive Chairman of the Board of ReViral
Prior to his current role, Ken had very extensive experience of the Biotechnology sector. In reverse order he was: Executive Chairman of Q-Chip a Cardiff, Wales based life science company developing novel delayed release formulations of drugs (merged with Midatech and the joint company listed on AIM in 2015). Founder and CEO of Arrow Therapeutics Ltd (a specialised antiviral drug discovery company acquired by Astra-Zeneca PLC for $150 million in February 2007). Professor at UCL and Deputy Director of the Wolfson Institute for Biomedical Research where he had responsibility for commercial activity including setting up five biotechnology start-up companies. He was a senior Pharmaceutical executive with the Wellcome Foundation which he decided to leave at the Wellcome/Glaxo merger. He has had a successful academic career in the UK and USA. He is an expert virologist and has been involved in the development of multiple drugs including anti-viral compounds against herpes viruses, HIV, Hepatitis C and RSV.
Follow Ken Powell:
About ReViral: ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
Jonathan Glenn
Chairman of Tissue Regenix
Follow Jonathan Glenn:
About Tissue Regenix: Tissue Regenix commercializes innovative technologies in regenerative medicine.
Noel Brady
Chairman of Moment Health
Noel brings learning and knowledge from previous roles in Government and global ICT, including Belfast Harbour Commissioner, and Financial Non-Executive Director for South Eastern Health Trust. As chairman of Moment Health, Noel supports the CEO and executive team, and leads business development and sales functions. “With more than 42 years experience in business in Northern Ireland, including 16 years in the public sector, I am delighted to chair a company as exciting as Moment Health. As a grandfather and father, I am proud to be involved in an initiative that is entirely focused on producing better outcomes for women and their wider family circle.”
Follow Noel Brady:
About Moment Health: Moment Health is a technology company focusing on providing early intervention for new and expectant parents suffering from antenatal.
Hugh Lloyd-Jukes
CEO and Chairman of Oxehealth
Hugh Lloyd-Jukes is the CEO and Chairman at Oxehealth.
Follow Hugh Lloyd-Jukes:
About Oxehealth: SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Barry Clare
Chairman of Evgen Pharma
Follow Barry Clare:
About Clarat: Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions
Maureen Coleman
Executive Chairman of CN Bio Innovations
Mrs Coleman has amassed over 20 years’ experience within the pharmaceutical industry, latterly as VP Global Strategy Development for GlaxoSmithKline. Since 2007 she has been working with a number of investor-backed companies including as founding Chief Executive of NovaThera, a regenerative medicine spin-out from Imperial College London, and as Director, Chairman and Chief Executive of life science spin-out companies from Oxford, Kings College, and Brunel Universities. Mrs Coleman is currently Chairman of Parafricta Ltd, a wound care materials business, and is a Director of MedInnovate Ltd, a technology consultancy spanning the healthcare industry. Mrs Coleman joined CN Bio Innovations in 2009 and became Chairman in 2011. She brings a wealth of sector relevant knowledge to the CNBIO team and experienced leadership in developing early stage life science businesses.
Follow Maureen Coleman:
About CN Bio Innovations, CN Bio Innovations, Parafricta: CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Prof Sir Michael Brady FRS FREng FMedSci
Chairman of Optellum
Follow Prof Sir Michael Brady FRS FREng FMedSci:
About Optellum: Optellum develops an imaging biomarker for smart lung cancer detection.
Christopher Getley
Chairman of AgPlus diagnostics
Over 25 years of experience at senior level in financial services including terms as a Director at Morgan Grenfell (subsequently Deutsche Bank) Asset Management and Partner at Cazenove & Co.Mr Getley has also been CEO of corporate advisory boutique Smith’s and corporate broker Westhouse Securities.He was responsible for the buyout of AgPlus Diagnostics from Serco Group plc in July 2015.He received a Combined Honours degree in Chemistry and Law from Exeter University in 1986.
Follow Christopher Getley:
About : Ag+ has been to deliver a rapid diagnostic platform technology .
Edward K. Aldag
Chairman, President and CEO of Medical Properties Trust
Edward K. Aldag is the Chairman, President, and CEO at Medical Properties Trust.
Follow Edward K. Aldag:
About Medical Properties Trust, MPT Operating Partnership: Medical Properties Trust, Inc. bridges the gap between the growing demand for high-quality healthcare.
James Otter
Co-founder and Executive Chairman of Renovos
James has extensive corporate commercial experience including a range of international management positions with Zeneca Agrochemicals and led a major turnaround while on the board of Spectris plc. Over the last 15 years he has focused on the bioscience SME sector, both as an investor while chairman of Hygea VCT and as CEO of several SMEs focused on imaging, drug delivery, telemedicine and cell culture. James brings a wealth of invaluable start-up, investment, governance and commercialisation experience to Renovos Biologics Ltd., essential to the role of Chairman.
Follow James Otter:
About Renovos: Providing orthopaedic regenerative medicine solutions
Trevor Smith
Chairman of Bedfont Scientific
Follow Trevor Smith:
About Bedfont Scientific: Bedfont Scientific specializes in the design and manufacture of exhaled breath and gas monitoring instruments.
